Insulinoma Flashcards

1
Q

What is an insulinoma

A

Malignant neoplasm of the pancreatic beta islet cells
In dogs, most common carcinomas
They behave aggressively and have mets by time of diagnosis
In histological examination most appear well
differentiated and with low mitotic index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is insulin secretion regulated

A

Glucose enters the islet cells
Metabolised to ATP. ATP closes the ATP sensitive K+ channels and opens the Ca channels resulting in insulin exocytosis

Hormones that counteract hypoglycaemia:
- Glucagon **imp**
‐ Catecholamines **imp**
‐ Growth hormone
‐ Glucocorticoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the typical signalement

A

Normally over 9 years

GSDs/ Labs possibly more commonly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are common clinical signs?

A

• From hypoglycemia (neuroglycopenia): seizures, collapse*, weakness, ataxia, lethargy, behavioural changes, even coma and death. Sometimes see neuropathies of the HLs
• Or from release release of catecolamines catecolamines: tremors tremors, hyperexcitability, nervousness, hunger
• In a recent case series the clinical signs were
reported more frequently during the summer months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do you diagnose an insulinoma

A

Hypoglycaemia with high insulin levels - if glucose levels are low (<3mmol/lt) insulin production should be inhibited
If patient is hypoglycemic and insulin levels are >20µU/ml that can confirm the disease but if levels are <20µU/ml (well within “normal” limits) they are still considered inappropriate and can be suggestive of insulinoma
Imaging - U/S and CT
low fructosamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the DDx for hypoglycaemia

A
Addisons
Sepsis
Other tumours (hepatocellular carcinoma, hepatoma, leiomyoma/sarcoma, haemangiosarcoma, plasmacytoma,mammary tumors etc
End stage hepatic failure
PSS
Toy breed and neonate hypoglycemia
Glycogen storage disease
Excessive exercise
Starvation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Outline the use of insulin testing

A

In some studies insulin levels are not always high and may need to be tested more than once

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How useful are different imaging modalities for diagnosis?

A

Radiography: poor technique to identify a pancreatic mass, but it should always be performed performed to rule out pulmonary pulmonary metastases metastases
(3 views)
‐ Ultrasonography: depends on expertise of operator and equipment (sensitivity approximately 50%), however most cases can be diagnosed with this technique
‐CT scan: sensitivity is not know, but in one study identified 70% of insulinomas
‐MRI scan: doesn’t appear to be better than CT scan , it is more expensive and not always available
‐Scintigraphy: administration of radioactive somatostatin, not easily available and not reliable
in dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do insulinomas appear physically?

A

Many insulinomas are solitary masses in one of the two limbs of the pancreas pancreas but multiple/nodular forms can also be seen Usually metastases are frequently seen in the abdomen (local LN, liver, omentum etc) and more rarely in the lungs

N.B Frequently older animals can have regenerative nodules in liver and spleen and that can cause confusion.
Cytological/histopathological examination is always necessary to reliably distinguish metastatic from non metastatic lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do you stage insulinomas?

A

• Stage I: tumor confined to pancreas (T1N0M0)
• Stage II: tumor in pancreas and local lymph nodes (T N M ) 1 1 0
• Stage III: tumor in pancreas, lymph nodes and metastases (T1N1M1 or T1N0M1)
• Most dogs have stage II or III disease at the
time of diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do you tx a hypoglycaemic crisis in the hospital?

A

‐ Apply an IV catheter
‐ Give glucose (0.5gr/kg IV) as a slow bolus diluted at least 1 3: in normal saline
‐ Continue with an IV CRI of 2.5‐5% glucose saline
‐ Monitor for hypoxia, cerebral oedema, hyperthermia, lung atelectasis from prolonged recumbency
• If animal fails to respond to glucose administer dexamethasone (0.1mg/kg IV BID)
• In severe cases patient may need to be sedated with diazepam or pentobarbital
• In one study a dog has been treated with glucagon CRI IV → clinical signs resolved within 20min

‐ Don’t give large amounts of glucose/dextrose,
start low and play it by ear - insulinomas can release further insulin in response to glucose administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Outline surgical treatment of insulinomas

A

• Prolonged survival in cases with early diagnosis
• Median survival time with partial pancreatectomy range from 1‐2 day associated with medical treatment
(prednisolone) can increase to 3.6y
• Surgical treatment should be considered in all stages if the patient is a suitable candidate for a GA
• Perioperative mortality is not very high and usually due to pancreatitis, arrhythmia or thromboembolic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the main medical treatment options

A
  • Frequent feedings
  • Prednisolone
  • Diazoxide
  • Glucagon
  • Streptozocin
  • Ocreotide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How should you feed an insulinoma patient?

A

‐ Diet high in protein, fat and complex carbohydrate
‐ Avoid simple sugars as they are absorbed very quickly
‐ Feed little and often (q4‐6h)
‐ Consider automated feeders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Outline the use of prednisolone

A

‐ Increases the gluconeogenesis, decreases the blood glucose uptake and stimulates glucagon release
‐ start low (0.5mg/kg day PO divided in BID) and increase. Never beyond 2mg/kg day PO (divided in bid) because of the side effects associated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Outline the use of diazoxide

A

‐ Benzothiazine derivate
‐ Inhibit insulin secretion and increases gluconeogenesis and glycogenolysis
‐ 10‐40mg/kg/day divided BID/TID (always start low)
‐ 70% success
‐ Side effects: vomiting, diarrea, tachycardia, pancreatitis, hypotension

17
Q

Outline the use of ocreotide

A

‐ Long acting somatostatin analogue
‐ Inhibits the secretion of insulin
‐ In humans is dependent on its binding affinity to any of 5 somatostatin receptors present in insulin secreting tumors
‐ In dogs only one somatostatin receptor identified
‐ Inhibits also GH and glucagon
‐ Can worsen hypoglycemia
‐ Cause pain at injection, nausea, vomiting, abdominal pain, constipation

18
Q

Outline the use of streptozocin

A

‐ Nitrosurea antibiotic (Streptomyces achromogenes)
‐ Directly Directly toxic to pancreatic pancreatic beta cells in pancreas and metastatic sites
‐ Highly nephrotoxic (tubular atrophy and renal failure)
‐ Can cause vomiting, DM, hypo/hyperglycemia,
haematological abnormalities
‐ Median survival time reported similar to controls (under surgical or medical treatment) but occasional long term remissions can be achieved